Hydramine and Baraclude drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hydramine (diphenhydramine hydrochloride) and Baraclude (entecavir). Common drug interactions include abdominal pain among females and decreased appetite among males.

The phase IV clinical study analyzes what interactions people have when they take Hydramine and Baraclude. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Hydramine?

Hydramine has active ingredients of diphenhydramine hydrochloride. It is often used in insomnia. eHealthMe is studying from 114,900 Hydramine users. Check the latest studies of Hydramine.

What is Baraclude?

Baraclude has active ingredients of entecavir. It is often used in hepatitis b. eHealthMe is studying from 6,175 Baraclude users. Check the latest studies of Baraclude.

On Jul, 14, 2026

18 people who take Hydramine and Baraclude together, and have interactions are studied.

Hydramine and Baraclude drug interactions.

What are the common drug interactions of Hydramine and Baraclude, by gender? *:

female:

Abdominal pain
Anaemia (lack of blood)
Anxiety
Cardiac disorder
Cough
Decreased appetite
Depression
Diarrhoea
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)

male:

Decreased appetite
Proteinuria (presence of protein in the urine)
Bk virus infection
Blood alkaline phosphatase increased
Bone marrow failure
Cell-mediated cytotoxicity (a cell destroys target cells)
Chylothorax (collection of lymph fluid around the lung)
Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
Constipation
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)

What are the common drug interactions of Hydramine and Baraclude, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Liver transplant

40-49:

n/a

50-59:

Bk virus infection
Bone marrow failure
Cell-mediated cytotoxicity (a cell destroys target cells)
Chylothorax (collection of lymph fluid around the lung)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Dehydration (dryness resulting from the removal of water)
Escherichia infection (bacterial infection by escherichia coli)
Lung disorder (lung disease)
Mucosal inflammation (infection of mucous membrane)
Pleural effusion (water on the lungs)

60+:

Decreased appetite
Anaemia (lack of blood)
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Headache (pain in head)
Hypoaesthesia (reduced sense of touch or sensation)
Malaise (a feeling of general discomfort or uneasiness)
Myalgia (muscle pain)
Nausea (feeling of having an urge to vomit)
Oedema peripheral (superficial swelling)

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 5 people, 27.78%
Constipation: 5 people, 27.78%
Cough: 4 people, 22.22%
High Blood Pressure: 4 people, 22.22%
Adult T-Cell Lymphoma/leukaemia (cancer of the immune system's own t-cells): 3 people, 16.67%
Pain: 3 people, 16.67%
Back Pain: 3 people, 16.67%
Diarrhea: 3 people, 16.67%
Hepatocellular Carcinoma (liver cancer): 3 people, 16.67%
Nausea (feeling of having an urge to vomit): 3 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Hydramine and Baraclude?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously